Effects of insulin therapy on liver fat content and hepatic insulin sensitivity in patients with type 2 diabetes

Glucose clamp technique: a method for quantifying insulin secretion and resistance.

DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425 · see citing works

Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease

Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604 · see citing works

Adiponectin and Adiponectin Receptors

Kadowaki, T., & Yamauchi, T. (2005) · Endocrine Reviews · doi:10.1210/er.2005-0005 · Cited by 2,634 · see citing works

Assessment of fat-free mass using bioelectrical impedance measurements of the human body

Lukaski, H., Johnson, P., Bolonchuk, W., & Lykken, G. (1985) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/41.4.810 · Cited by 1,896 · see citing works

The theoretical bases of indirect calorimetry: A review

Ferrannini, E. (1988) · Metabolism · doi:10.1016/0026-0495(88)90110-2 · Cited by 1,578 · see citing works

Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population

Szczepaniak, L. S., Nurenberg, P., Leonard, D. S., Browning, J. D., Reingold, J. S., Grundy, S. M., Hobbs, H. H., & Dobbins, R. L. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00064.2004 · Cited by 1,562 · see citing works

Disordered Fat Storage and Mobilization in the Pathogenesis of Insulin Resistance and Type 2 Diabetes

Lewis, G. F., Carpentier, A. C., Adeli, K., & Giacca, A. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.2.0461 · Cited by 1,328 · see citing works

The Effect of Thiazolidinediones on Plasma Adiponectin Levels in Normal, Obese, and Type 2 Diabetic Subjects

Yu, J. G., Javorschi, S., Hevener, A. L., Kruszynska, Y. T., Norman, R. A., Sinha, M. K., & Olefsky, J. M. (2002) · Diabetes · doi:10.2337/diabetes.51.10.2968 · Cited by 724 · see citing works

Measurement of intracellular triglyceride stores by H spectroscopy: validation in vivo

Szczepaniak, L. S., Babcock, E. E., Schick, F., Dobbins, R. L., Garg, A., Burns, D. K., McGarry, J. D., & Stein, D. T. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.276.5.e977 · Cited by 688 · see citing works

The Effects of Rosiglitazone on Insulin Sensitivity, Lipolysis, and Hepatic and Skeletal Muscle Triglyceride Content in Patients With Type 2 Diabetes

Mayerson, A. B., Hundal, R. S., Dufour, S., Lebon, V., Befroy, D., Cline, G. W., Enocksson, S., Inzucchi, S. E., Shulman, G. I., & Petersen, K. F. (2002) · Diabetes · doi:10.2337/diabetes.51.3.797 · Cited by 647 · see citing works

Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetes

Tiikkainen, M., Häkkinen, A.-M., Korsheninnikova, E., Nyman, T., Mäkimattila, S., & Yki-Järvinen, H. (2004) · Diabetes · doi:10.2337/diabetes.53.8.2169 · Cited by 524 · see citing works

The Effect of Insulin Treatment on Insulin Secretion and Insulin Action in Type II Diabetes Mellitus

Garvey, W. T., Olefsky, J. M., Griffin, J., Hamman, R. F., & Kolterman, O. G. (1985) · Diabetes · doi:10.2337/diab.34.3.222 · Cited by 488 · see citing works

Insulin glargine or NPH combined with metformin in type 2 diabetes: The LANMET study

Yki-Järvinen, H., Kauppinen-Mäkelin, R., Tiikkainen, M., Vähätalo, M., Virtamo, H., Nikkilä, K., Tulokas, T., Hulme, S., Hardy, K., McNulty, S., et al. (2006) · Diabetologia · doi:10.1007/s00125-005-0132-0 · Cited by 434 · see citing works

Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients.

Ryysy, L., Häkkinen, A. M., Goto, T., Vehkavaara, S., Westerbacka, J., Halavaara, J., & Yki-Järvinen, H. (2000) · Diabetes · doi:10.2337/diabetes.49.5.749 · Cited by 431 · see citing works

Decreased Plasma Adiponectin Concentrations Are Closely Related to Hepatic Fat Content and Hepatic Insulin Resistance in Pioglitazone-Treated Type 2 Diabetic Patients

Bajaj, M. S., Suraamornkul, S., Piper, P. K., Hardies, L. J., Glass, L. C., Cersósimo, E., Pratipanawatr, T., Miyazaki, Y., & DeFronzo, R. A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031315 · Cited by 354 · see citing works

Women and men have similar amounts of liver and intra-abdominal fat, despite more subcutaneous fat in women: implications for sex differences in markers of cardiovascular risk

Westerbacka, J., Corn�r, A., Tiikkainen, M., Tamminen, M., Vehkavaara, S., H�kkinen, A.-M., Fredriksson, J., & Yki-J�rvinen, H. (2004) · Diabetologia · doi:10.1007/s00125-004-1460-1 · Cited by 338 · see citing works

Quantification of liver fat using magnetic resonance spectroscopy

Thomsen, C., Becker, U., Winkler, K., Christoffersen, P., Jensen, M., & Henriksen, O. (1994) · Magnetic Resonance Imaging · doi:10.1016/0730-725x(94)92543-7 · Cited by 332 · see citing works

A microfluorometric method for the determination of free fatty acids in plasma

Miles, J., Glasscock, R., Aikens, J., Gerich, J. E., & Haymond, M. W. (1983) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38029-9 · Cited by 329 · see citing works

Comparison of insulin regimens in patients with non-insulin-dependent diabetes mellitus

Yki-Järvinen, H., Kauppila, M., Kujansuu, E., Lahti, J., Marjanen, T., Niskanen, L., Rajala, S., Ryysy, L., Salo, S., Seppälä, P., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199211123272005 · Cited by 324 · see citing works

Alterations in postprandial hepatic glycogen metabolism in type 2 diabetes.

Krssak, M., Brehm, A., Bernroider, E., Anderwald, C., Nowotny, P., Man, C. D., Cobelli, C., Cline, G. W., Shulman, G. I., Waldhäusl, W., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.12.3048 · Cited by 313 · see citing works

Combination therapies with insulin in type 2 diabetes

Yki-Järvinen, H. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.758 · Cited by 300 · see citing works

Pioglitazone Reduces Hepatic Fat Content and Augments Splanchnic Glucose Uptake in Patients With Type 2 Diabetes

Bajaj, M., Suraamornkul, S., Pratipanawatr, T., Hardies, L. J., Pratipanawatr, W., Glass, L. C., Cersósimo, E., Miyazaki, Y., & DeFronzo, R. A. (2003) · Diabetes · doi:10.2337/diabetes.52.6.1364 · Cited by 291 · see citing works

Fatty Infiltration of the Liver

Longo, R., RICC, C., Masutti, F., VIDIMARI, R., CROC, L. S., Bercich, L., Tiribelli, C., & Palma, L. D. (1993) · Investigative Radiology · doi:10.1097/00004424-199304000-00006 · Cited by 272 · see citing works

Effects of Identical Weight Loss on Body Composition and Features of Insulin Resistance in Obese Women With High and Low Liver Fat Content

Tiikkainen, M., Bergholm, R., Vehkavaara, S., Rissanen, A., Häkkinen, A.-M., Tamminen, M., Teramo, K., & Yki-Järvinen, H. (2003) · Diabetes · doi:10.2337/diabetes.52.3.701 · Cited by 271 · see citing works

Kinetics of glucose disposal in whole body and across the forearm in man.

Yki‐Järvinen, H., Young, A. A., Lamkin, C., & Foley, J. E. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113011 · Cited by 265 · see citing works

Intensive Conventional Insulin Therapy for Type II Diabetes: Metabolic effects during a 6-mo outpatient trial

Henry, R. R., Gumbiner, B., Ditzler, T., Wallace, P., Lyon, R., & Glauber, H. S. (1993) · Diabetes Care · doi:10.2337/diacare.16.1.21 · Cited by 227 · see citing works

Quantification of the relative impairment in actions of insulin on hepatic glucose production and peripheral glucose uptake in non-insulin-dependent diabetes mellitus

Campbell, P. J., Mandarino, L. J., & Gerich, J. E. (1988) · Metabolism · doi:10.1016/0026-0495(88)90023-6 · Cited by 226 · see citing works

Insulin Treatment Reverses the Insulin Resistance of Type II Diabetes Mellitus

Scarlett, J. A., Gray, R. S., Griffin, J., Olefsky, J. M., & Kolterman, O. (1982) · Diabetes Care · doi:10.2337/diacare.5.4.353 · Cited by 216 · see citing works

Effect of Rosiglitazone on Insulin Sensitivity and Body Composition in Type 2 Diabetic Patients

Carey, D., Cowin, G., Galloway, G. J., Jones, N. P., Richards, J. C., Biswas, N., & Doddrell, D. M. (2002) · Obesity Research · doi:10.1038/oby.2002.137 · Cited by 210 · see citing works

Insulin Therapy in Obese, Non-insulin-dependent Diabetes Induces Improvements in Insulin Action and Secretion that Are Maintained for Two Weeks After Insulin Withdrawal

Andrews, W. J., Vasquez, B., NAGULESPARAN, M., Klimeś, I., Foley, J. E., Unger, R. H., & Reaven, G. M. (1984) · Diabetes · doi:10.2337/diab.33.7.634 · Cited by 194 · see citing works

Rosiglitazone in the Treatment of Haart-Associated Lipodystrophy – a Randomized Double-Blind Placebo-Controlled Study

Sutinen, J., Häkkinen, A., Westerbacka, J., Seppälä‐Lindroos, A., Vehkavaara, S., Halavaara, J. T., Järvinen, A., Ristola, M. A., & Yki‐Järvinen, H. (2003) · Antiviral Therapy · doi:10.1177/135965350300800303 · Cited by 189 · see citing works

Increased fat accumulation in the liver in HIV-infected patients with antiretroviral therapy-associated lipodystrophy

Sutinen, J., Häkkinen, A.-M., Westerbacka, J., Seppälä-Lindroos, A., Vehkavaara, S., Halavaara, J., Järvinen, A., Ristola, M., & Yki-Järvinen, H. (2002) · AIDS · doi:10.1097/00002030-200211080-00011 · Cited by 184 · see citing works

Fat Accumulation in the Liver Is Associated with Defects in Insulin Suppression of Glucose Production and Serum Free Fatty Acids Independent of Obesity in Normal Men

Seppala-Lindroos, A. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.7.3023 · Cited by 168 · see citing works

Effects of Insulin Treatment in Type 2 Diabetic Patients on Intracellular Lipid Content in Liver and Skeletal Muscle

Anderwald, C. H., Bernroider, E., Krššák, M., Stingl, H., Brehm, A., Bischof, M. G., Nowotny, P., Roden, M., & Waldhäusl, W. K. (2002) · Diabetes · doi:10.2337/diabetes.51.10.3025 · Cited by 168 · see citing works

Abnormal meal carbohydrate disposition in insulin-dependent diabetes. Relative contributions of endogenous glucose production and initial splanchnic uptake and effect of intensive insulin therapy.

Pehling, G., Tessari, P., Gerich, J., Haymond, M., Service, F., & Rizza, R. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111519 · Cited by 132 · see citing works

Reduced capacity and affinity of skeletal muscle for insulin-mediated glucose uptake in noninsulin-dependent diabetic subjects. Effects of insulin therapy.

Baron, A., Laakso, M., Brechtel, G., & Edelman, S. V. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115117 · Cited by 127 · see citing works

Effects of Tolazamide and Exogenous Insulin on Insulin Action in Patients with Non-Insulin-Dependent Diabetes Mellitus

Firth, R. G., Bell, P. M., & Rizza, R. A. (1986) · New England Journal of Medicine · doi:10.1056/nejm198605153142003 · Cited by 122 · see citing works

The Fatty Liver and Insulin Resistance

Yki-Järvinen, H., & Westerbacka, J. (2005) · Current Molecular Medicine · doi:10.2174/1566524053766031 · Cited by 120 · see citing works

Insulin Decreases Human Adiponectin Plasma Levels

Möhlig, M., Wegewitz, U. E., Osterhoff, M. A., Isken, F., Ristow, M., Pfeiffer, A. F. H., & Spranger, J. (2002) · Hormone and Metabolic Research · doi:10.1055/s-2002-38248 · Cited by 117 · see citing works

A comparison of troglitazone and metformin on insulin requirements in euglycemic intensively insulin-treated type 2 diabetic patients.

Yu, J., Kruszynska, Y. T., Mulford, M. I., & Olefsky, J. M. (1999) · Diabetes · doi:10.2337/diabetes.48.12.2414 · Cited by 110 · see citing works

Improvement of Insulin Secretion but Not Insulin Resistance after Short Term Control of Plasma Glucose in Obese Type II Diabetics*

Hidaka, H., NAGULESPARAN, M., Klimeś, I., Clark, R. L., Sasaki, H., Aronoff, S. L., Vasquez, B., Rubenstein, A. H., & Unger, R. H. (1982) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-54-2-217 · Cited by 109 · see citing works

Effects of hypocaloric diet and insulin therapy on metabolic control and mechanisms of hyperglycemia in obese non-insulin-dependent diabetic subjects

Laakso, M., Uusitupa, M. I. J., Takala, J., Majander, H., Reijonen, T., & Penttilä, I. (1988) · Metabolism · doi:10.1016/0026-0495(88)90074-1 · Cited by 85 · see citing works

No Reduction in Total Hepatic Glucose Output by Inhibition of Gluconeogenesis With Ethanol in NIDDM Patients

Puhakainen, I., Koivisto, V. A., & Yki‐Järvinen, H. (1991) · Diabetes · doi:10.2337/diab.40.10.1319 · Cited by 76 · see citing works

Effect of Insulin Therapy on Insulin Resistance in Type II Diabetic Subjects: Evidence for Heterogeneity

Ginsberg, H. N., & Rayfield, E. J. (1981) · Diabetes · doi:10.2337/diab.30.9.739 · Cited by 76 · see citing works

Effects of Hyperglycemia on Glucose Production and Utilization in Humans: Measurement With [23H]-, [33H]-, and [614C]Glucose

Bell, P. M., Firth, R. G., & Rizza, R. A. (1986) · Diabetes · doi:10.2337/diab.35.6.642 · Cited by 73 · see citing works

Safety and Efficacy of Normalizing Fasting Glucose With Bedtime NPH Insulin Alone in NIDDM

Cusi, K. J., Cunningham, G. R., & Comstock, J. P. (1995) · Diabetes Care · doi:10.2337/diacare.18.6.843 · Cited by 72 · see citing works

Differential effects of insulin therapy on hepatic and peripheral insulin sensitivity in Type 2 (non-insulin-dependent) diabetes

Nankervis, A. J., Proietto, J., Aitken, P. M., Harewood, M. S., & ALFORD, F. P. (1982) · Diabetologia · doi:10.1007/bf00253737 · Cited by 56 · see citing works

Demonstration of a novel feedback mechanism between FFA oxidation from intracellular and intravascular sources

Yki‐Järvinen, H., Puhakainen, I., Saloranta, C., Groop, L., & Taskinen, M. (1991) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1991.260.5.e680 · Cited by 55 · see citing works

Clinical benefits and mechanisms of a sustained response to intermittent insulin therapy in type 2 diabetic patients with secondary drug failure

Yki-Järvinen, H., Esko, N., Helve, E., & Taskinen, M. (1988) · The American Journal of Medicine · doi:10.1016/0002-9343(88)90412-3 · Cited by 50 · see citing works

Treatment with intravenous insulin followed by continuous subcutaneous insulin infusion improves glycaemic control in severely resistant Type 2 diabetic patients

Pouwels, M.-J. J., Tack, C. J., Hermus, A. R. M. M., & Lutterman, J. A. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.00848.x · Cited by 48 · see citing works

Contribution of Impaired Muscle Glucose Clearance to Reduced Postabsorptive Systemic Glucose Clearance in NIDDM

Gerich, J. E., Mitrakou, A., Kelley, D., Mandarino, L. J., Nurjhan, N., Reilly, J., Jenssen, T. G., Veneman, T. F., & Consoli, A. (1990) · Diabetes · doi:10.2337/diab.39.2.211 · Cited by 40 · see citing works

One month's insulin treatment of type II diabetes: The early and medium-term effects following insulin withdrawal

Gormley, M. J. J., Hadden, D. R., Woods, R., Sheridan, B., & Andrews, W. J. (1986) · Metabolism · doi:10.1016/0026-0495(86)90039-9 · Cited by 38 · see citing works

Insulin therapy improves insulin actions on glucose metabolism and aortic wave reflection in type 2 diabetic patients

Tamminen, M., Westerbacka, J., Vehkavaara, S., & Yki‐Järvinen, H. (2003) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2003.01220.x · Cited by 19 · see citing works

Insulin Supplement in Type 2 Diabetic Patients with Secondary Failure to Oral Agents Ameliorates Hepatic and Peripheral Insulin Sensitivity but not Insulin Secretion

Pisu, E., Benedictis, D. D., Baggiore, C., Diana, A., Marengo, C., Bozzo, C., Renzetti, A. R., & Pagano, G. (1990) · Diabetic Medicine · doi:10.1111/j.1464-5491.1990.tb01496.x · Cited by 3 · see citing works

EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease

(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.004 · Cited by 4,836 · see citing works

American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings

Cusi, K., Isaacs, S., Barb, D., Basu, R., Caprio, S., Garvey, W. T., Kashyap, S., Mechanick, J. I., Mouzaki, M., Nadolsky, K., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.03.010 · Cited by 1,021 · see citing works

Role of Obesity and Lipotoxicity in the Development of Nonalcoholic Steatohepatitis: Pathophysiology and Clinical Implications

Cusi, K. J. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.02.003 · Cited by 917 · see citing works

Prediction of Non-Alcoholic Fatty Liver Disease and Liver Fat Using Metabolic and Genetic Factors

Kotronen, A., Peltonen, M., Hakkarainen, A., Sevastianova, K., Bergholm, R., Johansson, L., Lundbom, N. M. I., Rissanen, A., Ridderstråle, M., Groop, L., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.06.005 · Cited by 803 · see citing works

Fatty Liver

Kotronen, A., & Yki‐Järvinen, H. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.147538 · Cited by 787 · see citing works

Pathophysiology of diabetic dyslipidaemia: where are we?

Vergès, B. (2015) · Diabetologia · doi:10.1007/s00125-015-3525-8 · Cited by 708 · see citing works

EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease

European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), & European Association for the Study of Obesity (EASO) (2016) · Diabetologia · doi:10.1007/s00125-016-3902-y · Cited by 685 · see citing works

Non-alcoholic fatty liver disease: The mist gradually clears

de Alwis, N. M. W., & Day, C. P. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.01.009 · Cited by 603 · see citing works

Causes and Metabolic Consequences of Fatty Liver

Stefan, N., Kantartzis, K., & Häring, H. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0009 · Cited by 529 · see citing works

Non-alcoholic fatty liver disease and diabetes

Hazlehurst, J., Woods, C. P., Marjot, T., Cobbold, J., & Tomlinson, J. (2016) · Metabolism · doi:10.1016/j.metabol.2016.01.001 · Cited by 531 · see citing works

EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease

European Association for the Study of the Liver (EASL), E. A. F. T. S. O. D. (. (2016) · Obesity Facts · doi:10.1159/000443344 · Cited by 522 · see citing works

Effect of tirzepatide versus insulin degludec on liver fat content and abdominal adipose tissue in people with type 2 diabetes (SURPASS-3 MRI): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial

Gastaldelli, A., Cusi, K., Fernández Landó, L., Bray, R., Brouwers, B., & Rodríguez, Á. (2022) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(22)00070-5 · Cited by 513 · see citing works

Type 2 Diabetes

Taylor, R. (2013) · Diabetes Care · doi:10.2337/dc12-1805 · Cited by 485 · see citing works

Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor?

Bhatia, L. S., Curzen, N. P., Calder, P. C., & Byrne, C. D. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehr453 · Cited by 497 · see citing works

From the metabolic syndrome to NAFLD or vice versa?

Vanni, E., Bugianesi, E., Kotronen, A., Minicis, S. D., Yki‐Järvinen, H., & Svegliati‐Baroni, G. (2010) · Digestive and Liver Disease · doi:10.1016/j.dld.2010.01.016 · Cited by 494 · see citing works

From NASH to diabetes and from diabetes to NASH: Mechanisms and treatment options

Gastaldelli, A., & Cusi, K. (2019) · JHEP Reports · doi:10.1016/j.jhepr.2019.07.002 · Cited by 455 · see citing works

Radiologic evaluation of nonalcoholic fatty liver disease

Lee, S. S. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i23.7392 · Cited by 427 · see citing works

Non-invasive assessment of hepatic steatosis: Prospective comparison of the accuracy of imaging examinations

Lee, S. S., Park, S. H., Kim, H. J., Kim, S. Y., Kim, M.-Y., Kim, D. Y., Suh, D. J., Kim, K. M., Bae, M. H., Lee, J. Y., et al. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.01.008 · Cited by 372 · see citing works

Pathogenesis of type 2 diabetes: tracing the reverse route from cure to cause

Taylor, R. (2008) · Diabetologia · doi:10.1007/s00125-008-1116-7 · Cited by 352 · see citing works

Management of nonalcoholic fatty liver disease in patients with type 2 diabetes: a call to action

Bril, F., & Cusi, K. (2017) · Diabetes Care · doi:10.2337/dc16-1787 · Cited by 341 · see citing works

Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes.

Kotronen, A., Juurinen, L., Tiikkainen, M., Vehkavaara, S., & Yki–Järvinen, H. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.021 · Cited by 339 · see citing works

Nonalcoholic fatty liver disease and diabetes mellitus: pathogenesis and treatment

Smith, B. W., & Adams, L. A. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.72 · Cited by 327 · see citing works

The role of adiponectin in the pathogenesis and treatment of non‐alcoholic fatty liver disease

Pοlyzos, S. A., Kountouras, J., Zavos, C., & Tsiaousi, E. (2009) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01176.x · Cited by 277 · see citing works

Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus

Dharmalingam, M., & Yamasandhi, P. (2018) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_585_17 · Cited by 239 · see citing works

Insulin-independent regulation of hepatic triglyceride synthesis by fatty acids

Vatner, D. F., Majumdar, S. K., Kumashiro, N., Petersen, M. C., Rahimi, Y., Gattu, A. K., Bears, M., Camporez, J.-P. G., Cline, G. W., Jurczak, M. J., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1423952112 · Cited by 235 · see citing works

Parallel activation of de novo lipogenesis and stearoyl-CoA desaturase activity after 3 d of high-carbohydrate feeding

Chong, M. F., Hodson, L., Bickerton, A. S. T., Roberts, R., Neville, M. J., Karpe, F., Frayn, K. N., & Fielding, B. A. (2008) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.4.817 · Cited by 212 · see citing works

Liver fat is increased in type 2 diabetic patients and underestimated by serum alanine aminotransferase compared with equally obese nondiabetic subjects

Kotronen, A., Juurinen, L., Hakkarainen, A., Westerbacka, J., Cornér, A., Bergholm, R., & Yki-Järvinen, H. (2008) · Diabetes Care · doi:10.2337/dc07-1463 · Cited by 196 · see citing works

Non‐alcoholic fatty liver disease ( NAFLD ) prevalence and its metabolic associations in patients with type 1 diabetes and type 2 diabetes

Cusi, K. J., Sanyal, A. J., Zhang, S., Hartman, M. L., Bue‐Valleskey, J. M., Hoogwerf, B. J., & Haupt, A. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12973 · Cited by 188 · see citing works

Nonalcoholic fatty liver disease as a metabolic disease in humans: A literature review

Cariou, B., Byrne, C. D., Loomba, R. S., & Sanyal, A. J. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14322 · Cited by 174 · see citing works

Body composition changes in diabetes and aging

Al‐Sofiani, M. E., Ganji, S. S., & Kalyani, R. R. (2019) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2019.03.007 · Cited by 164 · see citing works

Nonalcoholic Fatty Liver Disease

Pοlyzos, S. A., Kountouras, J., Zavos, C., & Deretzi, G. (2012) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e31824587e0 · Cited by 152 · see citing works

Effects of Insulin Glargine and Liraglutide Therapy on Liver Fat as Measured by Magnetic Resonance in Patients With Type 2 Diabetes: A Randomized Trial

Tang, A., RABASA-LHORET, R. P. R., Castel, H., Wartelle‐Bladou, C., Gilbert, G., Massicotte-Tisluck, K., Chartrand, G., Olivié, D., Julien, A., de Guise, J. A., et al. (2015) · Diabetes Care · doi:10.2337/dc14-2548 · Cited by 133 · see citing works

Liraglutide or insulin glargine treatments improves hepatic fat in obese patients with type 2 diabetes and nonalcoholic fatty liver disease in twenty-six weeks: a randomized placebo-controlled trial

Guo, W., Tian, W., Lin, L., & Xu, X. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108487 · Cited by 126 · see citing works

Efficacy of exenatide and insulin glargine on nonalcoholic fatty liver disease in patients with type 2 diabetes

Liu, L., Yan, H., Xia, M., Zhao, L., Lv, M., Zhao, N., Rao, S., Yao, X., Wu, W., Pan, B., et al. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3292 · Cited by 119 · see citing works

Biopsy-proven Nonsteatotic Liver in Adults: Estimation of Reference Range for Difference in Attenuation between the Liver and the Spleen at Nonenhanced CT

Park, Y. S., Park, S. H., Lee, S. S., Kim, D. Y., Shin, Y. M., Lee, W., Lee, S., & Yu, E. S. (2011) · Radiology · doi:10.1148/radiol.10101233 · Cited by 118 · see citing works

Ectopic fat and insulin resistance

Lettner, A., & Roden, M. (2008) · Current Diabetes Reports · doi:10.1007/s11892-008-0032-z · Cited by 106 · see citing works

Hepatic Steatosis in Type 1 Diabetes

Regnell, S. E., & Lernmark, Å. (2011) · The Review of Diabetic Studies · doi:10.1900/rds.2011.8.454 · Cited by 105 · see citing works

The Contribution of Splanchnic Fat to VLDL Triglyceride Is Greater in Insulin-Resistant Than Insulin-Sensitive Men and Women

Hodson, L., Bickerton, A. S. T., McQuaid, S., Roberts, R., Karpe, F., Frayn, K. N., & Fielding, B. A. (2007) · Diabetes · doi:10.2337/db07-0654 · Cited by 102 · see citing works

Abnormal hepatic apolipoprotein B metabolism in type 2 diabetes

Vergès, B. L. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.01.028 · Cited by 95 · see citing works

Associations of erythrocyte fatty acids in the de novo lipogenesis pathway with risk of metabolic syndrome in a cohort study of middle-aged and older Chinese

Zong, G., Zhu, J., Sun, L., Ye, X., Lu, L., Jin, Q., He, Z., Yu, Z., Zhu, Z., Li, H., et al. (2013) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.061218 · Cited by 87 · see citing works

Nonalcoholic Fatty Liver Disease, Diabetes Mellitus and Cardiovascular Disease: Newer Data

Mavrogiannaki, A. N., & Migdalis, I. N. (2013) · International Journal of Endocrinology · doi:10.1155/2013/450639 · Cited by 87 · see citing works

Randomized Clinical Trial Comparing Basal Insulin Peglispro and Insulin Glargine in Patients With Type 2 Diabetes Previously Treated With Basal Insulin: IMAGINE 5

Buse, J. B., Rodbard, H. W., Serrano, C. T., Luo, J., Iványi, T., Bue‐Valleskey, J. M., Hartman, M. L., Carey, M. A., & Chang, A. M. (2015) · Diabetes Care · doi:10.2337/dc15-1531 · Cited by 82 · see citing works

The PNPLA3 I148M polymorphism is associated with insulin resistance and nonalcoholic fatty liver disease in a normoglycaemic population

Wang, C., Lin, H., Shin, S., Yu, M., Lin, Z., Dai, C., Huang, J., Chen, S., Li, S. S., & Chuang, W. (2011) · Liver International · doi:10.1111/j.1478-3231.2011.02526.x · Cited by 76 · see citing works

Non‐alcoholic fatty liver disease's prevalence and impact on alanine aminotransferase associated with metabolic syndrome in the Chinese

Hou, X., Zhu, Y., Lu, H., Chen, H., Li, Q., Jiang, S., Xiang, K., & Jia, W. (2010) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2010.06509.x · Cited by 73 · see citing works

Effects of exenatide, insulin, and pioglitazone on liver fat content and body fat distributions in drug-naive subjects with type 2 diabetes

Bi, Y., Zhang, B., Xu, W., Yang, H., Feng, W., Li, C., Tong, G., Li, M., Wang, X., Shen, S., et al. (2014) · Acta Diabetologica · doi:10.1007/s00592-014-0638-3 · Cited by 71 · see citing works

Comparative efficacy of anti‐diabetic agents on nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus: a systematic review and meta‐analysis of randomized and non‐randomized studies

Tang, W., Xu, Q., Hong, T., Tong, G., Feng, W., Shen, S., Bi, Y., & Zhu, D. (2015) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2713 · Cited by 63 · see citing works

Sodium-Glucose Co-Transporter 2 Inhibitors for Non-Alcoholic Fatty Liver Disease in Asian Patients With Type 2 Diabetes: A Meta-Analysis

Wong, C., Yaow, C. Y. L., Ng, C. H., Chin, Y. H., Low, Y. F., Lim, A. Y. L., Muthiah, M. D., & Khoo, C. M. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.609135 · Cited by 62 · see citing works

The Clinical Implications of Blood Adiponectin in Cardiometabolic Disorders

Chang, L., Huang, K., Wu, Y., Kao, H., Chen, C., Lai, L., Hwang, J., & Yang, W. (2009) · Journal of the Formosan Medical Association · doi:10.1016/s0929-6646(09)60079-6 · Cited by 60 · see citing works

Thiazolidinediones and the liver in humans

Yki‐Järvinen, H. (2009) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283321d37 · Cited by 59 · see citing works

Lipolysis, and Not Hepatic Lipogenesis, Is the Primary Modulator of Triglyceride Levels in Streptozotocin-Induced Diabetic Mice

Willecke, F., Scerbo, D. A., Nagareddy, P. R., Obunike, J. C., Barrett, T. J., Abdillahi, M., Trent, C. M., Huggins, L. A., Fisher, E. A. A., Drosatos, K., et al. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.304615 · Cited by 59 · see citing works

Role of Agents for the Treatment of Diabetes in the Management of Nonalcoholic Fatty Liver Disease

Budd, J. T., & Cusi, K. J. (2020) · Current Diabetes Reports · doi:10.1007/s11892-020-01349-1 · Cited by 61 · see citing works

Determinants of reversibility of β-cell dysfunction in response to short-term intensive insulin therapy in patients with early type 2 diabetes

Kramer, C. K., Choi, H., Zinman, B., & Retnakaran, R. R. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00447.2013 · Cited by 57 · see citing works

Liver Fat Content and Hepatic Insulin Sensitivity in Overweight Patients With Type 1 Diabetes

Llauradó, G., Sevastianova, K., Sädevirta, S., Hakkarainen, A., Lundbom, N. M. I., Orho‐Melander, M., Groop, P., Forsblom, C. M., & Yki‐Järvinen, H. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3050 · Cited by 55 · see citing works

Effects of intensive insulin therapy alone and in combination with pioglitazone on body weight, composition, distribution and liver fat content in patients with type 2 diabetes

Shah, P., Mudaliar, S. R. D., Chang, A. R., Aroda, V. R., André, M., Burke, P., & Henry, R. R. (2011) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01370.x · Cited by 56 · see citing works

Rosiglitazone Reduces Liver Fat and Insulin Requirements and Improves Hepatic Insulin Sensitivity and Glycemic Control in Patients with Type 2 Diabetes Requiring High Insulin Doses

Juurinen, L., Kotronen, A., Granér, M., & Yki‐Järvinen, H. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1825 · Cited by 56 · see citing works

Nonalcoholic Fatty Liver Disease: Epidemiology, Pathogenesis, Natural History, Diagnosis, and Current Treatment Options

Banini, B. A., & Sanyal, A. J. (2016) · Clinical Medicine Insights Therapeutics · doi:10.4137/cmt.s18885 · Cited by 52 · see citing works

n−3 polyunsaturated fatty acids modulate metabolism of insulin-sensitive tissues: implication for the prevention of type 2 diabetes

Pinel, A., Morio, B., & Capel, F. (2013) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-013-0303-2 · Cited by 48 · see citing works

Hepatopathy Associated With Type 1 Diabetes: Distinguishing Non-alcoholic Fatty Liver Disease From Glycogenic Hepatopathy

Mertens, J., Block, C. E. M. D., Spinhoven, M. J., Driessen, A. L. C., Francque, S., & Kwanten, W. J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.768576 · Cited by 46 · see citing works

Randomized, double‐blind clinical trial comparing basal insulin peglispro and insulin glargine, in combination with prandial insulin lispro, in patients with type 1 diabetes: IMAGINE 3

Bergenstal, R. M., Lunt, H., Franek, E., Travert, F., Mou, J., Qu, Y., Antalis, C. J., Hartman, M. L., Rosilio, M., Jacober, S. J., et al. (2016) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12698 · Cited by 47 · see citing works

Basal insulin peglispro versus insulin glargine in insulin‐naïve type 2 diabetes: IMAGINE 2 randomized trial

Davies, M. J., Russell-Jones, D. L., Selam, J. L., Bailey, T. S., Kerényi, Z., Luo, J., Bue‐Valleskey, J. M., Iványi, T., Hartman, M. L., Jacobson, J. G., et al. (2016) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12712 · Cited by 46 · see citing works

Liver-targeting drugs and their effect on blood glucose and hepatic lipids

Gastaldelli, A., Stefan, N., & Häring, H. (2021) · Diabetologia · doi:10.1007/s00125-021-05442-2 · Cited by 46 · see citing works

Randomized double‐blind clinical trial comparing basal insulin peglispro and insulin glargine, in combination with prandial insulin lispro, in patients with type 2 diabetes: IMAGINE 4

Blevins, T., Pieber, T. R., Vega, G. C., Zhang, S., Bastyr, E. J., Chang, A. M., & on behalf of the IMAGINE 4 Investigators (2016) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12696 · Cited by 45 · see citing works

Role of nonalcoholic fatty liver disease in the development of insulin resistance and diabetes

Grønbæk, H., Thomsen, K. L., Rungby, J., Schmitz, O., & Vilstrup, H. (2008) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2.5.705 · Cited by 42 · see citing works

Different effects of basal insulin peglispro and insulin glargine on liver enzymes and liver fat content in patients with type 1 and type 2 diabetes

Cusi, K. J., Sanyal, A. J., Zhang, S., Hoogwerf, B. J., Chang, A. M., Jacober, S. J., Bue-Valleskey, J. M., Higdon, A. N., Bastyr, E. J., Haupt, A., et al. (2016) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12751 · Cited by 40 · see citing works

Basal insulin peglispro: Overview of a novel long‐acting insulin with reduced peripheral effect resulting in a hepato‐preferential action

Jacober, S. J., PRINCE, M. J., Beals, J. M., Hartman, M. L., Qu, Y., Linnebjerg, H., Garhyan, P., & Haupt, A. (2016) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12744 · Cited by 39 · see citing works

Environmental and Genetic Determinants of Fatty Liver in Humans

Kantartzis, K., Schick, F., Häring, H., & Stefan, N. (2010) · Digestive Diseases · doi:10.1159/000282082 · Cited by 32 · see citing works

Predictors of Liver Fat and Stiffness in Non-Alcoholic Fatty Liver Disease (NAFLD) – an 11-Year Prospective Study

Lallukka, S., Sädevirta, S., Kallio, M. T., Luukkonen, P. K., Zhou, Y., Hakkarainen, A., Lundbom, N. M. I., Orho‐Melander, M., & Yki‐Järvinen, H. (2017) · Scientific Reports · doi:10.1038/s41598-017-14706-0 · Cited by 31 · see citing works

Liver insulinization as a driver of triglyceride dysmetabolism

Cook, J. R., Hawkins, M. A., & Pajvani, U. B. (2023) · Nature Metabolism · doi:10.1038/s42255-023-00843-6 · Cited by 32 · see citing works

Effects of insulin therapy on weight gain and fat distribution in the HF/HS-STZ rat model of type 2 diabetes

Skovsø, S., Damgaard, J., Fels, J. J., Olsen, G. S., Wolf, X. A., Rolin, B. C., & Holst, J. J. (2015) · International Journal of Obesity · doi:10.1038/ijo.2015.92 · Cited by 30 · see citing works

The potential role of fatty liver in paediatric metabolic syndrome: a distinct phenotype with high metabolic risk?

Nobili, V., Bedogni, G., Canani, R. B., Brambilla, P., Cianfarani, S., Pietrobelli, A., & Agostoni, C. V. (2012) · Pediatric Obesity · doi:10.1111/j.2047-6310.2012.00089.x · Cited by 27 · see citing works

Suppression of Rho-kinase 1 is responsible for insulin regulation of the AMPK/SREBP-1c pathway in skeletal muscle cells exposed to palmitate

Tang, S., Wu, W., Tang, W., Ge, Z., Wang, H., Hong, T., Zhu, D., & Bi, Y. (2017) · Acta Diabetologica · doi:10.1007/s00592-017-0976-z · Cited by 27 · see citing works

Role of Insulin Resistance and Diabetes in the Pathogenesis and Treatment of Nonalcoholic Fatty Liver Disease

Portillo-Sánchez, P., Yavuz, S., Bril, F., & Cusi, K. J. (2014) · Current Hepatology Reports · doi:10.1007/s11901-014-0229-3 · Cited by 25 · see citing works

Phagocytic function of Kupffer cells in mouse nonalcoholic fatty liver disease models: Evaluation with superparamagnetic iron oxide

Cheong, H., Lee, S. S., Lee, J. S., Kim, J., Kim, S. W., & Lee, W. J. (2014) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.24674 · Cited by 25 · see citing works

Modulation of gut microbiota contributes to effects of intensive insulin therapy on intestinal morphological alteration in high-fat-diet-treated mice

Wang, H., Tang, W., Zhang, P., Zhang, Z., He, J., Zhu, D., & Bi, Y. (2019) · Acta Diabetologica · doi:10.1007/s00592-019-01436-0 · Cited by 24 · see citing works

Non-alcoholic fatty liver disease in diabetes: When to refer to the hepatologist?

Khandelwal, R., Dassanayake, A. S., Conjeevaram, H. S., & Singh, S. P. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i9.1479 · Cited by 24 · see citing works

NAFLD vs MASLD (Metabolic Dysfunction–Associated Steatotic Liver Disease)—Why the Need for a Change of Nomenclature?

Gastaldelli, A., & Newsome, P. N. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf094 · Cited by 24 · see citing works

Lower mean blood glucose during short‐term intensive insulin therapy is associated with long‐term glycemic remission in patients with newly diagnosed type 2 diabetes: Evidence‐based recommendations for standardization

Liu, L., Liu, J., Xu, L., Ke, W., Wan, X., Li, H., He, X., Wang, L., Cao, X., Xiao, H., et al. (2017) · Journal of Diabetes Investigation · doi:10.1111/jdi.12782 · Cited by 22 · see citing works

Inhibition of obesity-induced hepatic ER stress by early insulin therapy in obese diabetic rats

Sun, W., Bi, Y., Liang, H., Cai, M., Chen, X. '., Zhu, Y., Li, M., Xu, F. L., Yu, Q.-Q., He, X., et al. (2010) · Endocrine · doi:10.1007/s12020-010-9429-y · Cited by 21 · see citing works

Correlational Study of Nonalcoholic Fatty Liver Disease Diagnosed by Ultrasonography with Lipid Profile and Body Mass Index in Adult Nepalese Population

Khanal, U. P., Paudel, B., Gurung, G., Hu, Y.-S., & Kuo, C.-W. (2019) · Journal of Medical Ultrasound · doi:10.4103/jmu.jmu_53_18 · Cited by 19 · see citing works

Frailty Is Associated with Oxidative Stress in Older Patients with Type 2 Diabetes

Alabadí, B., Civera, M., la Rosa, A. D., Martínez‐Hervás, S., Gómez‐Cabrera, M. C., & Real, J. T. (2021) · Nutrients · doi:10.3390/nu13113983 · Cited by 18 · see citing works

Effects of bed-time insulin versus pioglitazone on abdominal fat accumulation, inflammation and gene expression in adipose tissue in patients with type 2 diabetes

Hartemann, A., Halbron, M., Golmard, J., Jacqueminet, S., Bastard, J., Rouault, C., Ayed, A., Piéroni, L., Clément, K., & Grimaldi, A. (2009) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.06.028 · Cited by 17 · see citing works

Basal insulin combined incretin mimetic therapy with glucagon-like protein 1 receptor agonists as an upcoming option in the treatment of type 2 diabetes: a practical guide to decision making

Scholz, G. H., & Fleischmann, H. (2014) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018814556099 · Cited by 16 · see citing works

Fat accumulates preferentially in the right rather than the left liver lobe in non-diabetic subjects

Hua, B., Hakkarainen, A., Zhou, Y., Lundbom, N. M. I., & Yki‐Järvinen, H. (2017) · Digestive and Liver Disease · doi:10.1016/j.dld.2017.08.030 · Cited by 16 · see citing works

Role of anti-diabetic medications in the management of MASLD

Isaacs, S. D., Farrelly, F. V., & Brennan, P. (2025) · Frontline Gastroenterology · doi:10.1136/flgastro-2024-102856 · Cited by 17 · see citing works

Approach to the Patient With Nonalcoholic Fatty Liver Disease

Belfort‐DeAguiar, R., Lomonaco, R., & Cusi, K. J. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac624 · Cited by 15 · see citing works

The effect of dioxidovanadium complex (V) on hepatic function in streptozotocin-induced diabetic rats

Sibiya, S., Msibi, B., Khathi, A., Sibiya, N. H., Booysen, I. N., & Ngubane, P. S. (2019) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2019-0369 · Cited by 15 · see citing works

Effect of Insulin versus Triple Oral Therapy on the Progression of Hepatic Steatosis in Type 2 Diabetes

Lingvay, I., Roe, E. D., Duong, J., Leonard, D. S., & Szczepaniak, L. S. (2012) · Journal of Investigative Medicine · doi:10.2310/jim.0b013e3182621c5f · Cited by 14 · see citing works

Endogenous Chronic Hyperinsulinemia Does Not Increase the Production Rate of VLDL Apolipoprotein B: Proof from a Kinetic Study in Patients with Insulinoma

Duvillard, L., Florentin, E., Pont, F., Petit, J., Baillot-Rudoni, S., Penfornis, A., & Vergès, B. L. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2946 · Cited by 14 · see citing works

Insulin Resistance, Hepatic Lipid and Adipose Tissue Distribution in HIV-Infected Men

He, Q. W., Engelson, E. S., Ionescu, G. O., Glesby, M. J., Albu, J., & Kotler, D. P. (2008) · Antiviral Therapy · doi:10.1177/135965350801300309 · Cited by 13 · see citing works

Changes in markers of hepatic steatosis and fibrosis in patients with type 2 diabetes during treatment with glucagon-like peptide-1 receptor agonists. A multicenter retrospective longitudinal study

Morieri, M. L., Targher, G., Lapolla, A., D'Ambrosio, M., Tadiotto, F., Rigato, M., Frison, V., Paccagnella, A., Simioni, N., Avogaro, A., et al. (2021) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2021.08.049 · Cited by 12 · see citing works

Assessment of fatty liver and its correlation with glycemic control in patients with type 2 diabetes mellitus attending Dessie Comprehensive Specialized Hospital, Northeast Ethiopia

Abebe, G., Ayanaw, D., Mengstie, T. A., Dessie, G., & Malik, T. (2022) · SAGE Open Medicine · doi:10.1177/20503121221124762 · Cited by 11 · see citing works

Pivotal Role of Timely Basal Insulin Replacement After Metformin Failure in Sustaining Long-Term Blood Glucose Control at a Target in Type 2 Diabetes

Bolli, G. B., Lucidi, P., Porcellati, F., & Fanelli, C. G. (2011) · Diabetes Care · doi:10.2337/dc11-s224 · Cited by 11 · see citing works

High-fat-diet-induced hepatic insulin resistance per se attenuates murine de novo lipogenesis

Goedeke, L., Strober, J. W., Suh, R., Paolella, L. M., Li, X., Rogers, J. C., Petersen, M. C., Nasiri, A. R., Casals, G., Kahn, M., et al. (2024) · iScience · doi:10.1016/j.isci.2024.111175 · Cited by 10 · see citing works

An overview of insulin therapy for the non‐specialist

Home, P. D. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16280 · Cited by 10 · see citing works

Comparison of size of the liver between patients with non-alcoholic fatty liver disease and healthy controls

Dorostghol, M., Gharibvand, M. M., Hanafi, M. G., & Motamedfar, A. (2024) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_94_23 · Cited by 10 · see citing works

Metabolic drivers of MASLD and MASH: from hormonal imbalance to fibrosis

Gastaldelli, A., Scoditti, E., & Macedo, M. P. (2026) · Diabetologia · doi:10.1007/s00125-026-06774-7 · Cited by 11 · see citing works

Current approaches to diagnosing and treating nonalcoholic fatty liver disease

Никонов, Е. Л., & Va, A. (2018) · Russian Journal of Preventive Medicine · doi:10.17116/profmed201831262 · Cited by 9 · see citing works

The Effect of Early Intensive Insulin Therapy on Body Fat Distribution andβ-Cell Function in Newly Diagnosed Type 2 Diabetes

Son, J. W., Jeong, H. K., Lee, S. S., Kim, S. R., Cha, B., Son, H., & Yoo, S. J. (2013) · Endocrine Research · doi:10.3109/07435800.2012.745870 · Cited by 9 · see citing works

Effects of Exenatide and Humalog Mix25 on Fat Distribution, Insulin Sensitivity, and β-Cell Function in Normal BMI Patients with Type 2 Diabetes and Visceral Adiposity

Wang, X., Zhao, X., Gu, Y., Zhu, X., Yin, T., Tang, Z., Yuan, J., Chen, W., Ouyang, R., Yao, L., et al. (2020) · Journal of Diabetes Research · doi:10.1155/2020/9783859 · Cited by 9 · see citing works

Insulin treatment improves liver histopathology and decreases expression of inflammatory and fibrogenic genes in a hyperglycemic, dyslipidemic hamster model of NAFLD

Jensen, V. S., Fledelius, C., Zachodnik, C., Damgaard, J., Nygaard, H., Tornqvist, K. S., Kirk, R. K., Viuff, B. M., Wulff, E. M., Lykkesfeldt, J., et al. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-02729-1 · Cited by 9 · see citing works

Insulin therapy in type 2 diabetes : Initiation, impact on liver fat, role of combination therapy with glitazones or glindes

Juurinen, L. (2014) · Työväentutkimus Vuosikirja

Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes.

Kotronen, A., Juurinen, L., Tiikkainen, M., Vehkavaara, S., & Yki–Järvinen, H. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.021 · Cited by 339 · see citing works

Effects of Insulin Glargine and Liraglutide Therapy on Liver Fat as Measured by Magnetic Resonance in Patients With Type 2 Diabetes: A Randomized Trial

Tang, A., RABASA-LHORET, R. P. R., Castel, H., Wartelle‐Bladou, C., Gilbert, G., Massicotte-Tisluck, K., Chartrand, G., Olivié, D., Julien, A., de Guise, J. A., et al. (2015) · Diabetes Care · doi:10.2337/dc14-2548 · Cited by 133 · see citing works

CLINICAL-LIVER, PANCREAS, AND BILIARY TRACT Increased Liver Fat, Impaired Insulin Clearance, and Hepatic and Adipose Tissue Insulin Resistance in Type 2 Diabetes

Kotronen, A., Juurinen, L., Tiikkainen, M., & Vehkavaara, S. (2008)

Rosiglitazone Reduces Liver Fat and Insulin Requirements and Improves Hepatic Insulin Sensitivity and Glycemic Control in Patients with Type 2 Diabetes Requiring High Insulin Doses

Juurinen, L., Kotronen, A., Granér, M., & Yki‐Järvinen, H. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1825 · Cited by 56 · see citing works